9 September 2015
Horse Health Week Promotes the Seven Pillars of Equine Preventative Healthcare
Milton Keynes, September 09, 2015 – Booklets featuring the seven pillars of equine preventative healthcare will be available to vets, ready for the first Horse Health Week (HHW), starting on 21st September 2015.
HHW is a promotional week to support vets’ communications with their clients through educational materials for owners, news and features in the horse media, social media graphics and email templates as well as the updated website (www.healthyhorses.co.uk).
The series of horse health booklets have been created as a resource for vets, and are aimed at horse owners and potential owners. They cover what every horse owner should know about equine preventative healthcare, and how they contribute to the health, well-being and happiness of their horse. The booklets have been specially designed to communicate veterinary messages clearly and effectively.
The themes were identified by leading equine vets during a think tank session in September last year, including:
· Infectious diseases and vaccination - identification of symptoms, management, control and the role of biosecurity.
· Nutrition - including the basics of good feeding practice, monitoring bodyweight, and feeding to increase or decrease bodyweight.
· Hoof care - routine checks and every day care, identifying problems, preparing for the farrier and to shoe or not to shoe?
· Internal and external parasite control – identification and treatment of parasites, the use of faecal worm counts, targeted worming, wormer resistance and top tips to control worms.
· Teeth and dentistry - horse dentition explained, how to identify if a horse has problems, and what to expect during a dental examination.
· Well-being - the five freedoms and the responsibility of horse owners to understand how this translates to horse care, to stable or not during the winter, creating and maintaining a safe environment, the horse’s need for social interaction and space. It also covers preparing for euthanasia.
The booklets examine each topic, encouraging owners to contact their veterinary surgeon to get the latest advice and help. They also reference a number of reputable websites where owners can go for general information, such as where to find a qualified farrier, and the latest information on passports and identification.
Vets can download the booklets from the KBHH website (www.healthyhorses.so.uk).
About MSD Animal Health
Today's MSD is a global healthcare leader working to help the world be well. MSD Animal Health, known as Merck Animal Health in the United States and Canada, is the global animal health business unit of MSD. Through its commitment to theScience of Healthier Animals™, MSD Animal Health offers veterinarians, farmers, pet owners and governments one of the widest range of veterinary pharmaceuticals, vaccines and health management solutions and services. MSD Animal Health is dedicated to preserving and improving the health, well-being and performance of animals. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. MSD Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit www.msd-animal-health.com or connect with us on LinkedIn.
Forward-Looking Statement of Merck & Co., Inc., Kenilworth, N.J., USA
This news release of Merck & Co., Inc., Kenilworth, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2014 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).